Jun 21,2018

Artificial Intelligence-Powered Sugar.IQ Diabetes Management App Developed by Medtronic and IBM Watson Health Now Commercially Available

Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, and its strategic technology partner, IBM (NYSE:IBM) Watson Health, today announced commercial availability of the Sugar.IQ smart diabetes assistant, a first-of-its-kind intelligent app designed to simplify and improve daily diabetes management.

COLLABORATION PARTNERSHIP

#product & service

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 23,2018

Study Presented at the American Diabetes Association's 78th Scientific Sessions Shows Patients Using Contour Next One Smart Meter and App Reported Better Understanding and Engagement in Diabetes Management

This week at the American Diabetes Association 78th Scientific Sessions, data were presented from a study sponsored by Ascensia Diabetes Care that assessed user experience for the CONTOUR®NEXT ONE smart meter and app system. The results of this study are featured in three poster presentations that showed that the majority of subjects in the trial responded that the system would provide them with a better understanding of their diabetes and helped them feel more engaged with their diabetes self-management. The American Diabetes Association’s 78th Scientific Sessions are taking place in Orlando, Florida from June 22-26, 2018.

CLINICAL STUDY

#mobile app

#bgm

View Analyst & Ambassador Comments
Go to original news
Jun 24,2018

Insulet Presents Positive Clinical Trial Results for the Omnipod® Horizon™ Hybrid Closed-Loop System at the American Diabetes Association's 78th Scientific Sessions

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that positive results from the most recent clinical trial of the Omnipod® Horizon™ Automated Glucose Control System (Omnipod Horizon System) were presented during the American Diabetes Association (ADA) 78th Scientific Sessions in Orlando. The study demonstrated that the Omnipod Horizon System performed well and was safe for over five days of use in adults, adolescents, and children with type 1 diabetes.

CLINICAL STUDY

#insulin pump

#closed loop

View Analyst & Ambassador Comments
Go to original news
Jun 24,2018

MiniMed 670G System Real-World Data Show Improved Time in Range and Reduced Lows and Highs Across All Patient Groups Including a 41 Percent Time in Range Improvement for Previous MDI Patients

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for 32,178 users of the MiniMed 670G system. Data on more than 2 million patient days showed an average Time in Range of 70.6 percent across all age groups for those using the system's most advanced SmartGuard technology - the only smart algorithm that can adapt to fluctuating glucose levels and automatically self-adjust background insulin delivery.

CLINICAL STUDY

#insulin pump

#dtx

View Analyst & Ambassador Comments
Go to original news
Jun 25,2018

Roche expands access to the mySugr integrated diabetes management solution in the U.S. and Canada

Roche announced today that it has signed a collaboration agreement and investment in Care Innovations, a leader in telehealth solutions that remotely connects people living with chronic diseases with their care teams. Under the terms of the collaboration agreement, Roche and Care Innovations will integrate mySugr into the Care Innovations telehealth platform and provide connected remote care for integrated personalised diabetes and population health management to the broad range of Care Innovations’ customer base that includes health insurance companies, health networks and clinics. mySugr’s solution allows people with diabetes to receive advice from certified diabetes educators via the mySugr app and benefit from the convenience of having their diabetes management supplies including an Accu-Chek® Guide blood glucose meter and test strips delivered directly to their homes.

COLLABORATION PARTNERSHIP

#connected device

#telehealth

View Analyst & Ambassador Comments
Go to original news
Jun 25,2018

DarioHealth Presents New Data at American Diabetes Association's 78th Scientific Sessions on June 25, 2018

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported new data at the American Diabetes Association's (ADA) 78th Scientific Sessions which takes place in Orlando, Florida from June 22-26, 2018. On Monday June 25, 2018 from 12:00 pm – 1:00pm ET, DarioHealth's Head of Commercialization for North America, JC Muyl, is delivering three poster presentations.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jun 26,2018

One Drop Announces Blood Glucose Prediction and Automated Decision Support

One Drop, a leader in the development of digital therapeutics solutions for people with diabetes, today announced the launch of Blood Glucose Prediction and Automated Decision Support. Through these new features, the One Drop | Mobile app will provide users: (1) blood glucose "forecasts" up to 12 hours into the future; and (2) behavioral recommendations based on those forecasts, thereby empowering users to manage diabetes proactively and reduce the risk complications.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 28,2018

Medtronic Launches the MiniMed 670G System Performance Guarantee for Payers and Employers

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the launch of the MiniMed 670G Performance Guarantee Program - an outcomes-based offering for payers and employers designed to mitigate costs for diabetes-related complications. With this Guarantee, Medtronic will provide flat-fee reimbursements up to $25,000 per pump over 4 years for qualifying diabetes-related inpatient hospitalization and emergency room admissions for eligible in-network patients in the United States.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jul 02,2018

Blending high touch with high tech, Healthy Interactions adds depression, CVD modules

Healthy Interactions, a population health company that offers both digital and in-person programs for chronic disease management and education, announced last week that it has added two new programs, for cardiovascular disease and depression, to its portfolio. The company's initial focus was on diabetes, and it launched its original program, diabetes self-management education and support, in 2005.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Jul 06,2018

5 payers launch blockchain partnership, chronic disease tech released and more during Q2

This quarter saw a handful of digital health stories regarding payers and their new digital offerings, especially in the area of diabetes care. However, the past few months also saw headlines regarding CMS payments, payer-backed investigations into novel technologies, and other moves from insurers looking to better leverage digital healthcare. Read on for MobiHealthNews’ roundup of payer news from Q2 2018.

View Analyst & Ambassador Comments
Go to original news